Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could Viking Therapeutics Stock Be a Millionaire Maker?


There aren't many hotter stocks on the market right now than Viking Therapeutics (NASDAQ: VKTX). Shares of the biopharmaceutical company have skyrocketed around 340% so far this year.

However, those impressive gains might be just a start for Viking. The company should have plenty of potential catalysts over the next few years. Could Viking Therapeutics stock be a millionaire-maker?

Investors' excitement about Viking Therapeutics reached a fever pitch on Feb. 27, 2024, when the company announced the results from a phase 2 clinical study evaluating VK2735 in patients with obesity. Viking reported its experimental drug helped patients achieve a placebo-adjusted mean weight loss of up to 13.1% after 13 weeks of treatment. This reflected faster weight loss than Novo Nordisk's Wegovy and Ei Lilly's Zepbound achieved in their clinical trials.

Continue reading


Source Fool.com

Viking Therapeutics Inc Stock

€57.74
-1.170%
A loss of -1.170% shows a downward development for Viking Therapeutics Inc.

Like: 0
Share

Comments